More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. For American Heart Month, learn the facts behind this heart condition, plus one patient’s diagnosis story.
The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.
In many cases, it can take more than two years to diagnose this rare disease—and that delay can be deadly. For Pulmonary Hypertension Awareness Month, learn why Johnson & Johnson is on a mission to identify patients earlier by harnessing the power of artificial intelligence, smartphone apps and more.
Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.
Imagine having a disease that many doctors have never seen before. That’s what Marty Verel experienced when he was told he had AL amyloidosis—and it’s what hematologist Brendan Weiss, M.D., is determined to help change. For Rare Disease Day, Dr. Weiss shares what he’s learned studying the rare disease.
Black people are far more likely to live with cardiovascular diseases than other populations in the United States. We spoke to three experts about the consequences of that disparity—and how Johnson & Johnson is actively working to help drive change and better heart health through improved education, diagnosis and treatment.
Driving change: How Johnson & Johnson is using mobile healthcare to help address health inequities across the U.S.
From churches to schools—and even roving healthcare vans—the company has rolled out a program in states across the nation to help get COVID-19 testing and other crucial health services to underserved communities.
She oversees one of the world’s largest healthcare businesses: 7 questions for Ashley McEvoy in the time of COVID-19
Johnson & Johnson develops consumer products, medical devices and pharmaceuticals—and McEvoy is at the helm of its global Medical Devices Companies. She shares how she has navigated the pandemic, grown professionally and personally as a result, and helped impact the lives of millions during this unique moment in history.
Have you been putting off medical care this year out of concern about COVID-19? We asked a triple board-certified physician to share his best advice—and info about a new digital resource called My Health Can’t Wait—for how to ensure you aren’t putting your health at risk by waiting to schedule healthcare visits.
In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.